Literature DB >> 29555696

Hyperthermophilic Archaeon Thermococcus kodakarensis Utilizes a Four-Step Pathway for NAD+ Salvage through Nicotinamide Deamination.

Shin-Ichi Hachisuka1,2, Takaaki Sato1,2, Haruyuki Atomi3,2.   

Abstract

Many organisms possess pathways that regenerate NAD+ from its degradation products, and two pathways are known to salvage NAD+ from nicotinamide (Nm). One is a four-step pathway that proceeds through deamination of Nm to nicotinic acid (Na) by Nm deamidase and phosphoribosylation to nicotinic acid mononucleotide (NaMN), followed by adenylylation and amidation. Another is a two-step pathway that does not involve deamination and directly proceeds with the phosphoribosylation of Nm to nicotinamide mononucleotide (NMN), followed by adenylylation. Judging from genome sequence data, the hyperthermophilic archaeon Thermococcus kodakarensis is supposed to utilize the four-step pathway, but the fact that the adenylyltransferase encoded by TK0067 recognizes both NMN and NaMN also raises the possibility of a two-step salvage mechanism. Here, we examined the substrate specificity of the recombinant TK1676 protein, annotated as nicotinic acid phosphoribosyltransferase. The TK1676 protein displayed significant activity toward Na and phosphoribosyl pyrophosphate (PRPP) and only trace activity with Nm and PRPP. We further performed genetic analyses on TK0218 (quinolinic acid phosphoribosyltransferase) and TK1650 (Nm deamidase), involved in de novo biosynthesis and four-step salvage of NAD+, respectively. The ΔTK0218 mutant cells displayed growth defects in a minimal synthetic medium, but growth was fully restored with the addition of Na or Nm. The ΔTK0218 ΔTK1650 mutant cells did not display growth in the minimal medium, and growth was restored with the addition of Na but not Nm. The enzymatic and genetic analyses strongly suggest that NAD+ salvage in T. kodakarensis requires deamination of Nm and proceeds through the four-step pathway.IMPORTANCE Hyperthermophiles must constantly deal with increased degradation rates of their biomolecules due to their high growth temperatures. Here, we identified the pathway that regenerates NAD+ from nicotinamide (Nm) in the hyperthermophilic archaeon Thermococcus kodakarensis The organism utilizes a four-step pathway that initially hydrolyzes the amide bond of Nm to generate nicotinic acid (Na), followed by phosphoribosylation, adenylylation, and amidation. Although the two-step pathway, consisting of only phosphoribosylation of Nm and adenylylation, seems to be more efficient, Nm mononucleotide in the two-step pathway is much more thermolabile than Na mononucleotide, the corresponding intermediate in the four-step pathway. Although NAD+ itself is thermolabile, this may represent an example of a metabolism that has evolved to avoid the use of thermolabile intermediates.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  NAD salvage; Thermococcus; archaea; hyperthermophiles; metabolism; nicotinamide adenine dinucleotide

Mesh:

Substances:

Year:  2018        PMID: 29555696      PMCID: PMC5952396          DOI: 10.1128/JB.00785-17

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  43 in total

1.  Biosynthesis of diphosphopyridine nucleotide. I. Identification of intermediates.

Authors:  J PREISS; P HANDLER
Journal:  J Biol Chem       Date:  1958-08       Impact factor: 5.157

2.  Biosynthesis of diphosphopyridine nucleotide. II. Enzymatic aspects.

Authors:  J PREISS; P HANDLER
Journal:  J Biol Chem       Date:  1958-08       Impact factor: 5.157

3.  Effect of alkali on diphosphopyridine nucleotide.

Authors:  N O KAPLAN; S P COLOWICK; C C BARNES
Journal:  J Biol Chem       Date:  1951-08       Impact factor: 5.157

4.  Biochemical characterization of glyceraldehyde-3-phosphate dehydrogenase from Thermococcus kodakarensis KOD1.

Authors:  Baolei Jia; Le Thuy Linh; Sangmin Lee; Bang Phuong Pham; Jinliang Liu; Hongyu Pan; Shihong Zhang; Gang-Won Cheong
Journal:  Extremophiles       Date:  2011-03-16       Impact factor: 2.395

5.  In vitro evaluation of nicotinamide riboside analogs against Haemophilus influenzae.

Authors:  C P Godek; M H Cynamon
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

6.  Comparative genomics of NAD biosynthesis in cyanobacteria.

Authors:  Svetlana Y Gerdes; Oleg V Kurnasov; Konstantin Shatalin; Boris Polanuyer; Roman Sloutsky; Veronika Vonstein; Ross Overbeek; Andrei L Osterman
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

Review 7.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 8.  Molecular biology of pyridine nucleotide and nicotine biosynthesis.

Authors:  Akira Katoh; Takashi Hashimoto
Journal:  Front Biosci       Date:  2004-05-01

9.  Structure of l-aspartate oxidase from the hyperthermophilic archaeon Sulfolobus tokodaii.

Authors:  Haruhiko Sakuraba; Kazunari Yoneda; Issaku Asai; Hideaki Tsuge; Nobuhiko Katunuma; Toshihisa Ohshima
Journal:  Biochim Biophys Acta       Date:  2008-01-08

10.  Identification and characterization of an archaeal ketopantoate reductase and its involvement in regulation of coenzyme A biosynthesis.

Authors:  Hiroya Tomita; Tadayuki Imanaka; Haruyuki Atomi
Journal:  Mol Microbiol       Date:  2013-08-27       Impact factor: 3.501

View more
  2 in total

Review 1.  An overview of 25 years of research on Thermococcus kodakarensis, a genetically versatile model organism for archaeal research.

Authors:  Naeem Rashid; Mehwish Aslam
Journal:  Folia Microbiol (Praha)       Date:  2019-07-08       Impact factor: 2.099

2.  A Structurally Novel Lipoyl Synthase in the Hyperthermophilic Archaeon Thermococcus kodakarensis.

Authors:  Jian-Qiang Jin; Shin-Ichi Hachisuka; Takaaki Sato; Tsuyoshi Fujiwara; Haruyuki Atomi
Journal:  Appl Environ Microbiol       Date:  2020-11-10       Impact factor: 4.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.